Leech Nitric Oxide Synthase Modulator
Modulates host NOS activity at bite site — contributes to vasodilation phase of feeding.
- Hementerin80 kDa
- Hementin80 kDa
- Hementin-Like Protein (HLP-1)80 kDa
- Leech Collagenase70 kDa
- Haemadipsa yanyuanensis Progranulin (Hy-PGRN)70 kDa
- Leech Apyrase67 kDa
- Calin65 kDa
- Hyaluronidase60 kDa
- Antithrombin III binding protein58 kDa
- Collagenolytic Fibrinolysin55 kDa
- Leech Thrombospondin-Like Protein50 kDa
- Leech Nitric Oxide Synthase Modulator22 kDa
Mechanistic Evidence Box
Preclinical / mechanistic: Evidence is preclinical (in vitro, animal models, or mechanism-of-action research). Clinical efficacy in humans has not been established.- Page type
- Compound profile
- Evidence type
- Preclinical / biochemical characterization
- Evidence level
- Mechanistic discussion
- Drug vs leech
- Leech-derived crude extract
Clinical translation limit
The vasodilatory role of leech NOS modulation at the bite site is mechanistic only and does not establish clinical efficacy for any vasodilation-related indication. No FDA-approved derivative exists.
Molecular Profile
- Category
- Vasodilator
- Evidence tier
- Preclinical
- Molecular weight
- 22,000 Da
- Source species
- Hirudo medicinalis
Biological Targets
- → nitric oxide synthase (NOS) pathway
External Resources
Related Vasodilator Compounds
Leech Histamine-like Vasodilator
Histamine-receptor-acting compound — contributes to local vasodilation at feeding site.
Leech Acetylcholine
Cholinergic vasodilator contributing to feeding-site vascular dilation.
Leech Bradykinin Modulator
Salivary factor reported to modulate the bradykinin / kinin-kallikrein vasoactive cascade.
Shuxuetong (SXT) Injection Active Peptides
Three angiogenic peptides (DSYVGDEAQSKR, YNELRVAPEEHP, IQFLPEGSPVTM) from a leech + earthworm Shuxuetong (SXT) injection — Sun 2022 hindlimb-ischemia model.